PreEvnt Isaac is a groundbreaking device that's finally solved the puzzle of measuring blood glucose without needing to prick your skin. This wearable, which you can wear like a necklace, uses a clever technology that measures volatile organic compounds in your breath to detect biomarkers associated with rising blood sugar levels. The idea came from Bud Wilcox's grandson, who was diagnosed with type 1 diabetes at just two years old, highlighting the need for an easy and non-invasive method of monitoring blood sugar levels.
The device's development has been a long time coming, with initial prototypes showcased at CES 2025. Since then, it has undergone human clinical trials at Indiana University, comparing its performance to traditional blood glucose monitoring methods in adolescents with type 1 diabetes and adults with type 2 diabetes.
PreEvnt Isaac's design is sleek and compact, allowing for easy wear around the neck or storage in a bag. When you breathe onto it, the device calculates your blood sugar levels and logs them into the companion smartphone app, which also includes features such as logging food intake and providing access to emergency contacts.
While other companies are also developing products related to metabolic tracking, including monitoring food intake and blood sugar for weight loss or peak performance, PreEvnt Isaac is notable for its origins in addressing quality-of-life issues for individuals with diabetes. As the technology continues to be refined through clinical trials and FDA authorization, it offers a beacon of hope for those struggling with this condition.
The company behind PreEvnt Isaac is taking a unique approach to regulatory approval, as they are using a "de novo" application pathway that allows them to educate and collaborate with the FDA while their device undergoes assessment. This collaborative approach shows promise for getting non-invasive blood sugar tracking into consumers' hands sooner rather than later.
As we move forward in this rapidly evolving space of health technologies, it's reassuring to see innovative solutions addressing real-world problems like diabetes management. With PreEvnt Isaac on the horizon, people with blood sugar concerns may soon find themselves breathing a sigh of relief – and not just because they're exhaling onto a wearable device!
The device's development has been a long time coming, with initial prototypes showcased at CES 2025. Since then, it has undergone human clinical trials at Indiana University, comparing its performance to traditional blood glucose monitoring methods in adolescents with type 1 diabetes and adults with type 2 diabetes.
PreEvnt Isaac's design is sleek and compact, allowing for easy wear around the neck or storage in a bag. When you breathe onto it, the device calculates your blood sugar levels and logs them into the companion smartphone app, which also includes features such as logging food intake and providing access to emergency contacts.
While other companies are also developing products related to metabolic tracking, including monitoring food intake and blood sugar for weight loss or peak performance, PreEvnt Isaac is notable for its origins in addressing quality-of-life issues for individuals with diabetes. As the technology continues to be refined through clinical trials and FDA authorization, it offers a beacon of hope for those struggling with this condition.
The company behind PreEvnt Isaac is taking a unique approach to regulatory approval, as they are using a "de novo" application pathway that allows them to educate and collaborate with the FDA while their device undergoes assessment. This collaborative approach shows promise for getting non-invasive blood sugar tracking into consumers' hands sooner rather than later.
As we move forward in this rapidly evolving space of health technologies, it's reassuring to see innovative solutions addressing real-world problems like diabetes management. With PreEvnt Isaac on the horizon, people with blood sugar concerns may soon find themselves breathing a sigh of relief – and not just because they're exhaling onto a wearable device!